Secondary Logo

Journal Logo

Scientific Review

Association Between Depressive Symptoms and Exercise Capacity in Patients With Heart Disease

A META-ANALYSIS

Papasavvas, Theodoros MSc; Alhashemi, Mohammad MD; Micklewright, Dominic PhD

Author Information
Journal of Cardiopulmonary Rehabilitation and Prevention: July 2017 - Volume 37 - Issue 4 - p 239–249
doi: 10.1097/HCR.0000000000000193

Cardiovascular diseases are the number one cause of death globally.1 In 2010, approximately 800 000 people died of cardiovascular diseases in the United States, accounting for one-third of all deaths.2 The major modifiable contributors to cardiovascular disease mortality are high blood pressure, tobacco use, unhealthy diet and obesity, insufficient physical activity, and abnormal glucose levels.3 Other risk factors associated with heart disease include dyslipidemia and harmful use of alcohol,1 as well as emerging risk factors such as depression4 and anxiety.5

The abovementioned risk factors also worsen prognosis in patients with established heart disease or after acute coronary syndrome. Depression, which is evident in nearly 20% of these patients,6 is associated with a 2.25-fold risk of all-cause mortality after myocardial infarction7 and has been recommended by the American Heart Association as a risk factor for poor prognosis following acute coronary syndrome.8 The risk for all-cause mortality in patients suffering from heart failure is increased by 51% in the presence of depression.9

Insufficient physical activity leads to poor fitness, which, in patients with established heart disease or after acute coronary syndrome, is also associated with poor prognosis. Fitness can be objectively assessed by determining exercise capacity using a symptom-limited exercise test. Low exercise capacity in these patients is associated with a more than 2-fold risk of all-cause mortality compared with high exercise capacity.10

Given the abovementioned clinical significance of depression and exercise capacity in this population, expected outcomes for patients enrolled in cardiac rehabilitation programs include the absence of clinically significant depressive symptoms and a clinically significant increase in exercise capacity.11 A potential interaction between these 2 variables may therefore be of substantial clinical importance in assessment, risk stratification, goal setting, therapeutic intervention, and rehabilitation. Studies assessing a correlation between depressive symptoms and exercise capacity in patients suffering from heart disease are few; however, this correlation can be assessed in every study that reports measures of depressive symptoms and exercise capacity, regardless of whether this is the purpose of the study or not. We therefore conducted a meta-analysis including studies from which correlations between depressive symptoms and exercise capacity could be calculated.

METHODS

ELIGIBILITY CRITERIA

Studies published between January 2000 and September 2013 were inspected. The restriction to recent studies was decided on the rationale that access to the raw database of the studies in order to calculate correlations would be needed and the availability of such databases would diminish with time. Experimental and observational studies on adult patients with coronary artery disease, heart failure, congenital heart disease, and implantable cardioverter defibrillator (ICD), alone and with comorbid depression (mild, moderate, or major), published and unpublished in English were eligible for inclusion. Studies on patients with comorbid depression were eligible in order for the total range of depressive symptoms to be used for calculating the correlation between depressive symptoms and exercise capacity. Studies that reported correlation(s) between depressive symptoms and exercise capacity, as well as studies from which such correlations could be calculated, were included. Depressive symptoms were measured using validated depression scales. Exercise capacity was measured (1) in the case of cardiopulmonary exercise testing, using a symptom-limited exercise test and reported as peak oxygen uptake (

O2peak); (2) with treadmill exercise testing, estimated metabolic equivalents (METs) at maximum workload or in watts with cycle ergometer testing; and (3) total distance covered in the case of incremental shuttle walk testing (ISWT). Heart transplantation studies were excluded.

INFORMATION SOURCES

A systematic computerized literature search in the databases of PubMed, Cochrane Library, Google Scholar, and ProQuest, covering articles from January 2000 to September 2013, was conducted. ProQuest contains unpublished theses, the inclusion of which reduces publication bias. References of included studies were also reviewed, and principal investigators of included studies were asked to provide relevant published or unpublished studies.

SEARCH

The titles and abstracts (PubMed), titles (Google Scholar), abstracts (ProQuest), and full text (Cochrane Library) of studies were searched using the following search terms: exercise AND depress*; card* AND depress*; heart AND depress*; stress test* AND depress*; aerobic capacity AND depress*; fitness AND depress*; oxygen uptake AND depress*;

O2max AND depress*;

O2peak AND depress*; and rehabilitation AND depress*

All search terms were followed by NOT menopause NOT pregnant NOT postpartum NOT postnatal NOT fibromyalgia NOT Parkinson's NOT stroke NOT sclerosis NOT spinal cord NOT lumbar NOT low back NOT spondylitis NOT osteoarthritis NOT fracture NOT musculoskeletal NOT cancer NOT bipolar NOT binge NOT adolescent* NOT rat, except in the Google Scholar search.

STUDY SELECTION AND DATA COLLECTION

All potentially relevant studies, judged from title and abstract, were either acquired in full text or their authors were contacted and asked whether an exercise capacity metric (

O2peak, METs, maximum watts, and total distance covered in the ISWT) and a depression scale score had been reported. Studies reporting one of the abovementioned exercise capacity metrics and a depression scale score or correlation between them were included. Authors of such studies were contacted, and the raw data or the correlations were requested.

DATA ITEMS

The correlation between depressive symptoms and exercise capacity was the only data item and was either reported or calculated from the included studies. One correlation coefficient per study was calculated and included in the analysis. If a study had more than 1 group, the correlation for the total cohort was calculated. If a study had more than 1 measurement, the correlation at baseline was calculated.

RISK OF BIAS IN INDIVIDUAL STUDIES

To reduce the risk of selective outcome reporting and to eliminate the bias of lack of blinding of the participants and researchers in prospective studies, the correlation between depressive symptoms and exercise capacity at baseline only was reported or calculated.

SUMMARY MEASURES

Pearson (or Spearman, in case of nonparametric data) correlation coefficients between a depression scale score and an exercise capacity metric were used to create the summary measure. A random-effects model was used, since there is no current knowledge of the effect of moderators (eg, gender, age) on the true effect size.

PLANNED METHOD OF ANALYSIS

The method of Hedges and Vevea12 was used for synthesizing the correlation coefficients. In this method, the correlations are converted to the Fisher z scale and the analysis is performed using the transformed values. Then, the results, such as summary effect and 95% CIs, are converted back to correlations. This method of converting correlations to Fisher z values was chosen to eliminate the bias in the correlation variance, since it depends strongly on the correlation itself.

Any excessive inconsistency (between-studies variation) is considered to reflect true differences between studies and is termed heterogeneity. Heterogeneity was assessed using the Cochran Q χ2 test and using I2, which represents the percentage of the total variation that is attributed to true differences between studies. Confidence (uncertainty) intervals for I2 were also calculated. MIX 2.0 (Biostat, Englewood, NJ) and Comprehensive Meta-Analysis software (Biostat, Englewood, NJ) were used for statistical analysis.

RISK OF BIAS ACROSS STUDIES

Publication bias was assessed visually on a funnel plot (effect size by the inverse of its standard error) and statistically using the Egger test, the Begg and Mazumdar rank correlation test, and the Trim and Fill method. It should be mentioned, however, that other factors such as study quality and true heterogeneity can produce asymmetry in funnel plots. Duplication was avoided by juxtaposing author names, study sample size, gender, and age. In cases of ambiguity, the authors were contacted. Availability bias (selective inclusion of studies that are easily accessible to the researcher), with regard to omitting studies from which the required data were difficult to acquire, was addressed by contacting all authors of the study, by regular (biweekly) followups, and by collecting data for a period of 12 months. The Rosenthal Fail-safe N statistic was also used to calculate the number of missing studies that would render the summary effect nonsignificant.

ADDITIONAL ANALYSES

Prespecified exclusion sensitivity analysis was performed to assess the effect of exclusion of each study (one at a time) on the summary effect. Post hoc subgroup analyses were performed using a Q-test based on analysis of variance for random-effects model with pooled estimate of τ2 (between-studies dispersion) with the following moderators: gender, with 2 levels: male and female; disease with 2 levels: coronary artery disease and heart failure; exercise test with 4 levels: cardiopulmonary exercise test, simple treadmill test, watts-based cycle ergometer test, and ISWT. Prespecified meta-regression was performed to assess the effect of age on the effect sizes.

RESULTS

STUDY SELECTION

A total of 59 studies were included in the analysis. The search of all databases provided a total of 23 508 citations. Of these, 21 627 studies were discarded after reading the title and/or abstract, since it was clear that they did not meet the criteria. The remaining 1881 studies were acquired in full text or their authors were contacted and asked whether depression and exercise capacity had been assessed. Of these, 1543 and 229 studies were discarded because there was no assessment of depression and/or exercise capacity and because exercise capacity was measured using a submaximal test (eg, 6-minute walk test), respectively. Of the remaining 109 eligible studies, 16 studies were duplicates or shared the same sample whereas 34 studies were not included because it was impossible to acquire the data from their authors (Figure 1).

Figure 1
Figure 1:
Flow diagram of study selection process.

STUDY CHARACTERISTICS

Fifty-eight published studies and 1 unpublished thesis13 were included, totaling 25 733 participants. Eleven studies reported a correlation between depressive symptoms and exercise capacity, and authors of the remaining 48 studies were contacted and provided the raw data or the correlations. Studies were experimental and observational, and the majority included patients with coronary artery disease and heart failure. One study included patients with congenital heart disease,14 and 2 studies included patients with ICD15,16 (Table 1).

Table 1
Table 1:
Characteristics of Included Studies

RISK OF BIAS WITHIN STUDIES

Typical sources of bias within studies, such as lack of concealment of randomization and patient blinding, were not assessed because this meta-analysis used only the baseline data for the total cohort. However, data collector blinding at baseline was assessed because it may affect baseline measurements. Baseline measurements that were conducted before randomization were considered collector blind. Of the 26 studies in which collector blinding was applicable, 15 included collector blinding. The results can be seen in Table 2.

Table 2
Table 2:
Risk of Bias Within Studies

RESULTS OF INDIVIDUAL STUDIES

Effect sizes, including sample size, 95% CI, z-statistic, and study weights for the individual studies are reported in Table 3.

Table 3
Table 3:
Details of All Effects Sizes

SYNTHESES OF RESULTS

The summary correlation coefficient was −0.15 with a 95% CI from −0.17 to −0.12 (Figure 2). Heterogeneity was statistically significant (I2 = 64% with a 95% CI from 52 to 73; Q = 161; df = 58; P < .001).

Figure 2
Figure 2:
Forest plot of effect sizes. CC indicates correlation coefficient.

RISK OF BIAS ACROSS STUDIES

The visual impression of the heterogeneity funnel plot (effect size by the inverse of its standard error) showed no sign of publication bias (Figure 3). This was confirmed statistically using the Egger test (intercept was −0.51 with a 95% CI from −1.15 to 0.13, and a 1-tailed P = .06) and the Begg and Mazumdar rank correlation test (Kendall τ was −0.05 with a 1-tailed P = .29). The Rosenthal Fail-safe N was 4681. The Trim and Fill method using the MIX software did not suggest inputting studies; however, the Comprehensive Meta-Analysis software suggested inputting 4 studies, adjusting the summary effect to −0.14 with a 95% CI from −0.17 to −0.12.

Figure 3
Figure 3:
Funnel plot of effect size by precision. CC indicates correlation coefficient.

ADDITIONAL ANALYSES

Exclusion sensitivity analysis (the effect of exclusion of each study to the summary effect) did not show clinically significant findings. The greatest positive shift was after the exclusion of the studies of Jolly et al17 or Mroszczyk-McDonald et al18 (summary effect −0.14 with a 95% CI from −0.17 to −0.12), and the greatest negative shift was after the exclusion of several studies and affected only the 95% CI (summary effect −0.15 with a 95% CI from −0.18 to −0.13).

The subgroup analysis based on gender did not show statistically significant results (Q = 0.05; df = 1; P = .8). The subgroup analysis based on disease did not show statistically significant results (Q = 0.07; df = 1; P = .8). The subgroup analysis based on the exercise test did not show statistically significant results (Q = 5.3; df = 3; P = .15).

The slope of the meta-regression of participant age on the effect sizes was not statistically significant (the slope was −0.001 with a P value of .2).

DISCUSSION

The results of this study showed a modest correlation (r = −0.15; 95% CI, −0.17 to −0.12) between depressive symptoms and exercise capacity in patients with heart disease that was irrelevant to gender, disease type, and type of exercise test.

One plausible explanation of this relationship is behavioral. The higher the depressive symptoms, the weaker was the motivation to engage in physical activity, which can result in reduced exercise capacity. Indeed, there is evidence that physical activity is associated with depression19 and that depression may be a significant risk factor for developing a sedentary lifestyle.20 Another plausible explanation of the relationship between depressive symptoms and exercise capacity is biological. There is strong evidence that exercise improves cognitive abilities and enhances brain neuroplasticity.21 Levels of brain-derived neurotrophic factor, which is involved in cellular analogues of memory formation, plasticity, and cell proliferation, are reduced in depression and can be increased with aerobic exercise.22 Moreover, inflammation is present in depression23 whereas levels of inflammatory markers, such as C-reactive protein, are inversely associated with cardiorespiratory fitness in patients with heart disease.24

The association between depressive symptoms and exercise capacity in patients with heart disease has implications regarding patient assessment and treatment plan. Clinicians should consider that patients with poor exercise capacity may tend to have elevated depressive symptoms and thus may consider conducting a more thorough psychosocial evaluation of this patient group; they may also be prepared to anticipate depression-related challenges, such as poor adherence to treatment, including rehabilitation.25 Furthermore, clinicians may consider elevated depressive symptoms in the differential diagnosis of poor exercise capacity, in addition to other factors, such as age, function of cardiovascular and pulmonary systems, body weight, carbohydrate intake, and physical activity,26 in patients with heart disease. Finally, it may be possible that the reduced exercise capacity observed in patients with elevated depressive symptoms is a result of suboptimal exercise test performance due to poor motivation, which could prevent the detection of potential ischemia.27 Perhaps, a cardiopulmonary exercise test, in which performance of the subject can be objectively assessed by using the respiratory exchange ratio ≥1.1 as a test termination criterion,28 would be more appropriate for patients with heart disease and elevated depressive symptoms.

The association between depressive symptoms and exercise capacity in patients with heart disease also has implications regarding patient care. Because of the linear relationship between depressive symptoms and exercise capacity, it should be considered that even elevated depressive symptoms (not major depressive disorder) may affect exercise capacity. This is of clinical importance because the prevalence of subclinical depression is significantly larger than that of a major depressive disorder in patients with heart disease29 and it may predict mortality30 after myocardial infarction. Even small reductions in exercise capacity may affect mood. This is of clinical importance, especially not only for cardiac rehabilitation programs where the majority of patients entering cardiac rehabilitation exhibit poor exercise capacity31 but also for all patients with heart disease where exercise capacity is a strong predictor of mortality.10 Conversely, even small increases in exercise capacity may improve mood and reduce depression-related increased mortality in patients with coronary heart disease32 and heart failure.33

Furthermore, the abovementioned association warrants a multidimensional approach to treating depression and improving exercise capacity in patients with heart disease. Regardless of whether there is unidirectional causation, bidirectional causation, or the influence of other variable(s), conducting research on the effects of treating the one on the other is warranted. Improving exercise capacity through exercise interventions may reduce depressive symptoms. There is evidence that exercise is superior to placebo in reducing depressive symptoms in patients with coronary artery disease34; however, more research is needed in order for the optimum frequency, intensity, type, and duration of exercise to be determined, as well as for assessing whether the effect is transient or longer-lasting. Reducing depressive symptoms might improve exercise capacity. There is evidence that psychological and pharmacological interventions for depression reduce depressive symptoms in patients with coronary artery disease,35 but, to our knowledge, their effects on exercise capacity have not been studied.

Finally, the association between depressive symptoms and exercise capacity in patients with heart disease further supports the status of depression as a risk factor for poor prognosis following acute coronary syndrome8 and it adds to the pool of evidence that links depression to worse prognosis in patients with heart failure, since depression is associated with an established strong and independent predictor of mortality in this patient group. The abovementioned clinical and prognostic implications of this association also support the American Heart Association's recommendation for depression screening in patients with coronary heart disease36 and advocates for the extension of this recommendation to patients with heart failure.

LIMITATIONS

It was not possible to assess the effects of potential moderators of the association between depressive symptoms and exercise capacity, such as age, gender, body mass index, physical activity, and medication, in within-study level because raw data were not available for every study. Between-study analysis was only possible for gender and age, using subgroup analysis and meta-regression, respectively.

Within- and across-studies bias should be taken into consideration. Blinding of data collectors was performed in 15 of 26 applicable studies. Only studies in English language were included, and, although publication bias was not significant, it should be mentioned that 34 eligible studies (see Supplemental Digital Content 1, available at: http://links.lww.com/JCRP/A27) were not included in the analysis because it was impossible to acquire the necessary additional data from their authors.

In summary, patients with heart disease and elevated depressive symptoms may tend to have reduced exercise capacity, and vice versa. This finding has implications for patient assessment, plan of care, treatment, rehabilitation, and prognosis. It also encourages research on the effects of improving depression on exercise capacity, and vice versa. The effects of potential moderators and mediators need to be explored.

REFERENCES

1. World Health Organization. Global status report on noncommunicable diseases 2010. http://http://www.who.int/nmh/publications/ncd_report2010/en. Accessed May 2015.
2. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep. 2013;62(6):1–96.
3. Yang Q, Cogswell ME, Flanders WD, et al Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–1283.
4. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–1372.
5. Pereira VH, Cerqueira JJ, Palha JA, Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int J Cardiol. 2013;166(1):30–37.
6. Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):511–523.
7. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33(3):203–216.
8. Lichtman JH, Froelicher ES, Blumenthal JA, et al Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–1369.
9. Fan H, Yu W, Zhang Q, et al Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med. 2014;63:36–42.
10. Kavanagh T, Mertens DJ, Hamm LF, et al Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002;106(6):666–671.
11. Balady GJ, Williams MA, Ades PA, et al Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev. 2007;27(3):121–129.
12. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998;3(4):486–504.
13. Reschke AH. Depression and Functional Impairment in Outpatients with Congestive Heart Failure [dissertation]. Saint Louis, MO: Department of Psychology, Washington University; 2000.
14. Muller J, Hess J, Hager A. Minor symptoms of depression in patients with congenital heart disease have a larger impact on quality of life than limited exercise capacity. Int J Cardiol. 2012;154(3):265–269.
15. Dougherty CM, Glenny R, Kudenchuk PJ. Aerobic exercise improves fitness and heart rate variability after an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev. 2008;28(5):307–311.
16. Śmiałek J, Lelakowski J, Majewski J. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator. Kardiol Pol. 2013;71(10):1021–1028.
17. Jolly K, Taylor R, Lip GY, et al The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technol Assess. 2007;11(35):1–118.
18. Mroszczyk-McDonald A, Savage PD, Ades PA. Handgrip strength in cardiac rehabilitation: normative values, interaction with physical function, and response to training. J Cardiopulm Rehabil Prev. 2007;27(5):298–302.
19. Strohle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm. 2009;116(6):777–784.
20. Roshanaei-Moghaddam B, Katon WJ, Russo J. The longitudinal effects of depression on physical activity. Gen Hosp Psychiatry. 2009;31(4):306–315.
21. Hotting K, Roder B. Beneficial effects of physical exercise on neuroplasticity and cognition. Neurosci Biobehav Rev. 2013;37(9, pt B):2243–2257.
22. Erickson KI, Miller DL, Roecklein KA. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist. 2012;18(1):82–97.
23. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186.
24. Lavie CJ, Church TS, Milani RV, Earnest CP. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. 2011;31(3):137–145.
25. Pogosova N, Saner H, Pedersen SS, et al Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22(10):1290–1306.
26. Laukkanen JA, Laaksonen D, Lakka TA, et al Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol. 2009;103(11):1598–1604.
27. Lavoie KL, Fleet RP, Lesperance F, et al Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Am Heart J. 2004;148(4):621–627.
28. Balady GJ, Arena R, Sietsema K, et al Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.
29. Moudgil R, Haddad H. Depression in heart failure. Curr Opin Cardiol. 2013;28(2):249–258.
30. Carney RM, Freedland KE, Steinmeyer B, et al Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord. 2008;109(1/2):133–138.
31. Ades PA, Savage PD, Brawner CA, et al Aerobic capacity in patients entering cardiac rehabilitation. Circulation. 2006;113(23):2706–2712.
32. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120(9):799–806.
33. Milani RV, Lavie CJ, Mehra MR, Ventura HO. Impact of exercise training and depression on survival in heart failure due to coronary heart disease. Am J Cardiol. 2011;107(1):64–68.
34. Blumenthal JA, Sherwood A, Babyak MA, et al Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60(12):1053–1063.
35. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2011;9:CD008012.
36. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–1775.
37. Ades PA, Savage PD, Tischler MD, Poehlman ET, Dee J, Niggel J. Determinants of disability in older coronary patients. Am Heart J. 2002;143(1):151–156.
38. Ades PA, Savage P, Cress ME, Brochu M, Lee NM, Poehlman ET. Resistance training on physical performance in disabled older female cardiac patients. Med Sci Sports Exerc. 2003;35(8):1265–1270.
39. Asbury EA, Webb CM, Probert H, et al Cardiac rehabilitation to improve physical functioning in refractory angina: a pilot study. Cardiology. 2012;122(3):170–177.
40. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int J Nurs Stud. 2011;48(1):3–12.
41. Benzer W, Platter M, Oldridge NB, et al Short-term patient-reported outcomes after different exercise-based cardiac rehabilitation programmes. Eur J Cardiovasc Prev Rehabil. 2007;14(3):441–447.
42. Bettencourt N, Dias C, Mateus P, et al Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome. Rev Port Cardiol. 2005;24(5):687–696.
43. Bunevicius A, Stankus A, Brozaitiene J, Girdler SS, Bunevicius R. Relationship of fatigue and exercise capacity with emotional and physical state in patients with coronary artery disease admitted for rehabilitation program. Am Heart J. 2011;162(2):310–316.
44. De Schutter A, Lavie CJ, Milani RV. Relative importance of comorbid psychological symptoms in patients with depressive symptoms following phase II cardiac rehabilitation. Postgrad Med. 2011;123(6):72–78.
45. Duarte Freitas P, Haida A, Bousquet M, Richard L, Mauriege P, Guiraud T. Short-term impact of a 4-week intensive cardiac rehabilitation program on quality of life and anxiety-depression. Ann Phys Rehabil Med. 2011;54(3):132–143.
    46. Evangelista LS, Moser DK, Westlake C, Pike N, Ter-Galstanyan A, Dracup K. Correlates of fatigue in patients with heart failure. Prog Cardiovasc Nurs. 2008;23(1):12–17.
    47. Faulkner J, Westrupp N, Rousseau J, Lark S. A randomized controlled trial to assess the effect of self-paced walking on task-specific anxiety in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev. 2013;33(5):292–296.
    48. Freyssin C, Verkindt C, Prieur F, Benaich P, Maunier S, Blanc P. Cardiac rehabilitation in chronic heart failure: effect of an 8-week, high-intensity interval training versus continuous training. Arch Phys Med Rehabil. 2012;93(8):1359–1364.
    49. Gottlieb SS, Kop WJ, Ellis SJ, et al Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol. 2009;103(9):1285–1289.
    50. Guck TP, Kinney M, Anazia G, Williams MA. Relationship between acceptance of illness and functional outcomes following cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2012;32(4):187–191.
    51. Houchen L, Watt A, Boyce S, Singh S. A pilot study to explore the effectiveness of “early” rehabilitation after a hospital admission for chronic heart failure. Physiother Theory Pract. 2012;28(5):355–358.
    52. Hughes JW, Casey E, Luyster F, et al Depression symptoms predict heart rate recovery after treadmill stress testing. Am Heart J. 2006;151(5):1122.e1121–e1126.
    53. Hughes AR, Mutrie N, Macintyre PD. Effect of an exercise consultation on maintenance of physical activity after completion of phase III exercise-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil. 2007;14(1):114–121.
    54. Izawa KP, Oka K, Watanabe S, et al Gender-related differences in clinical characteristics and physiological and psychosocial outcomes of Japanese patients at entry into phase II cardiac rehabilitation. J Rehabil Med. 2008;40(3):225–230.
    55. Jackson JL, Emery CF. Emotional distress, alexithymia, and coping as predictors of cardiac rehabilitation outcomes and attendance. J Cardiopulm Rehabil Prev. 2013;33(1):26–32.
    56. Jolly K, Taylor RS, Lip GY, et al A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study. Eur J Heart Fail. 2009;11(2):205–213.
    57. Karapolat H, Demir E, Bozkaya YT, et al Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters. Clin Res Cardiol. 2009;98(10):635–642.
    58. Karlsson MR, Edstrom-Pluss C, Held C, Henriksson P, Billing E, Wallen NH. Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. J Behav Med. 2007;30(3):253–261.
    59. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010;3(6):659–667.
    60. Knackstedt C, Arndt M, Mischke K, et al Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy. Heart Vessels. 2014;29(3):364–374.
    61. Koukouvou G, Kouidi E, Iacovides A, Konstantinidou E, Kaprinis G, Deligiannis A. Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure. J Rehabil Med. 2004;36(1):36–41.
    62. Kulcu DG, Kurtais Y, Tur BS, Gulec S, Seckin B. The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results. Eura Medicophys. 2007;43(4):489–497.
    63. Laederach-Hofmann K, Roher-Gubeli R, Messerli N, Meyer K. Comprehensive rehabilitation in chronic heart failure—better psycho-emotional status related to quality of life, brain natriuretic peptide concentrations, and clinical severity of disease. Clin Invest Med. 2007;30(2):E54–E62.
    64. Marchionni N, Fattirolli F, Fumagalli S, et al Determinants of exercise tolerance after acute myocardial infarction in older persons. J Am Geriatr Soc. 2000;48(2):146–153.
    65. Meyer T, Buss U, Herrmann-Lingen C. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med. 2010;72(1):9–15.
    66. Mourot L, Boussuges A, Maunier S, et al Cardiovascular rehabilitation in patients with diabetes. J Cardiopulm Rehabil Prev. 2010;30(3):157–164.
    67. Reid RD, Dafoe WA, Morrin L, et al Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: results of a randomized trial. Am Heart J. 2005;149(5):862–868.
    68. Rocha A, Araujo V, Parada F, Maciel MJ, Azevedo A. Age does not determine the physical, functional and psychosocial response to a cardiac rehabilitation program. Rev Port Cardiol. 2011;30(5):479–507.
    69. Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H. Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil. 2007;14(4):547–554.
    70. Ruo B, Rumsfeld JS, Pipkin S, Whooley MA. Relation between depressive symptoms and treadmill exercise capacity in the Heart and Soul Study. Am J Cardiol. 2004;94(1):96–99.
    71. Salzwedel A, Nosper M, Rohrig B, Linck-Eleftheriadis S, Strandt G, Voller H. Outcome quality of in-patient cardiac rehabilitation in elderly patients—identification of relevant parameters. Eur J Prev Cardiol. 2014;21(2):172–180.
      72. Sanjuan P, Arranz H, Castro A. Effect of negative attributions on depressive symptoms of patients with coronary heart disease after controlling for physical functional impairment. Br J Health Psychol. 2014;19(2):380–392.
      73. Seki E, Watanabe Y, Sunayama S, et al Effects of phase III cardiac rehabilitation programs on health-related quality of life in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circ J. 2003;67(1):73–77.
      74. Silberman A, Banthia R, Estay IS, et al The effectiveness and efficacy of an intensive cardiac rehabilitation program in 24 sites. Am J Health Promot. 2010;24(4):260–266.
      75. Skobel EC, Sinha AM, Norra C, et al Effect of cardiac resynchronization therapy on sleep quality, quality of life, and symptomatic depression in patients with chronic heart failure and Cheyne-Stokes respiration. Sleep Breath. 2005;9(4):159–166.
      76. Smart NA, Murison R. Rate of change in physical fitness and quality of life and depression following exercise training in patients with congestive heart failure. Congest Heart Fail. 2013;19(1):1–5.
      77. Spaderna H, Zahn D, Schulze Schleithoff S, et al Depression and disease severity as correlates of everyday physical activity in heart transplant candidates. Transpl Int. 2010;23(8):813–822.
      78. Stauber S, Schmid JP, Saner H, Saner G, Grolimund J, von Kanel R. A comparison of psychosocial risk factors between 3 groups of cardiovascular disease patients referred for outpatient cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2012;32(4):175–181.
      79. Steinberg G, Lossnitzer N, Schellberg D, et al Peak oxygen uptake and left ventricular ejection fraction, but not depressive symptoms, are associated with cognitive impairment in patients with chronic heart failure. Int J Gen Med. 2011;4:879–887.
        80. Suzuki S, Takaki H, Yasumura Y, et al Assessment of quality of life with 5 different scales in patients participating in comprehensive cardiac rehabilitation after acute myocardial infarction. Circ J. 2005;69(12):1527–1534.
        81. Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctot KL. Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease. J Rehabil Med. 2008;40(3):213–218.
        82. Swardfager W, Herrmann N, Marzolini S, et al Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. J Clin Psychiatry. 2011;72(9):1181–1188.
        83. Turner SC, Bethell HJ, Evans JA, Goddard JR, Mullee MA. Patient characteristics and outcomes of cardiac rehabilitation. J Cardiopulm Rehabil. 2002;22(4):253–260.
        84. van den Berg-Emons R, Balk A, Bussmann H, Stam H. Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure? Eur J Heart Fail. 2004;6(1):95–100.
        85. Vizza J, Neatrour DM, Felton PM, Ellsworth DL. Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program. J Cardiopulm Rehabil Prev. 2007;27(6):376–383; quiz 384-385.
        86. von Kanel R, Saner H, Kohls S, et al Relation of heart rate recovery to psychological distress and quality of life in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2009;16(6):645–650.
        87. Yeh GY, McCarthy EP, Wayne PM, et al Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med. 2011;171(8):750–757.
        88. Yeh GY, Wood MJ, Wayne PM, et al Tai chi in patients with heart failure with preserved ejection fraction. Congest Heart Fail. 2013;19(2):77–84.
        Keywords:

        cardiac rehabilitation; depression; exercise capacity; mortality; prognosis

        Supplemental Digital Content

        Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.